Editorial: Resistance to endocrine therapies in cancer, volume II.

Chakrabarty, Anindita; Hiscox, Stephen; Ranganathan, Prathibha

Chakrabarty, Anindita; Hiscox, Stephen; Ranganathan, Prathibha.

Afiliação

Chakrabarty A; Department of Life Sciences, Shiv Nadar Institution of Eminence, Delhi, NCR, India.
Hiscox S; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Ranganathan P; Center For Human Genetics (CHG), Bengaluru, India.

Front Endocrinol (Lausanne) ; 15: 1414392, 2024.

Article em En | MEDLINE | ID: mdl-38715800

Assuntos

Antineoplásicos Hormonais; Resistencia a Medicamentos Antineoplásicos; Neoplasias; Humanos; Antineoplásicos Hormonais/uso terapêutico; Neoplasias/tratamento farmacológico

Palavras-chave

androgen; breast cancer; endocrine therapy; estrogen; prostate cancer; resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google